Intermec (IN) Misses Q3 EPS by 1c; Guides In-Line for Q4
Tweet
Share
E-mailGet Alerts IN Hot Sheet
Price: $10.00 --0%
Financial Fact:
Cost of service revenues: 21.55M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Cost of service revenues: 21.55M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Intermec (NYSE: IN) reported Q3 EPS of $0.09, $0.01 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $211.8 million versus the consensus estimate of $222.76 million.
Intermec sees Q4 2011 EPS of $0.16-$0.21, versus the consensus of $0.18. Intermec sees Q4 2011 revenue of $235-$245 million, versus the consensus of $246.63 million.
Intermec sees Q4 2011 EPS of $0.16-$0.21, versus the consensus of $0.18. Intermec sees Q4 2011 revenue of $235-$245 million, versus the consensus of $246.63 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
- Innovaro (INV) Misses Q2 EPS by 9c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
